Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 1308
Selected: 0
NCT IDTitle
NCT00165438Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
NCT00441142Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors
NCT03070145Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy
NCT01582841Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting
NCT02943642Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
NCT00130702Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
NCT00782275Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
NCT00153907Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer
NCT00307736Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
NCT06518564Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
NCT04040725Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
NCT03161431SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab
NCT02176031Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
NCT00376480Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant
NCT01921335ARRY-380 + Trastuzuamab for Breast w/ Brain Mets
NCT01024946Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
NCT07624513Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma
NCT00593060Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
NCT02523040Lenalidomide for Adult Histiocyte Disorders
NCT01659203Proton or Photon RT for Retroperitoneal Sarcomas
NCT02022982PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors
NCT07232043ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
NCT00520013Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
NCT02644382Improving Surgical Decision-making in Young Women With Breast Cancer
NCT00821080Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
NCT02919670A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
NCT00020670Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
NCT01078961An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
NCT03514680Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy
NCT01294670Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
NCT03277482Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
NCT03482557Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
NCT05632328AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
NCT00590902Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
NCT00119730Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
NCT00137813Avastin and Taxotere for Esophagogastric Cancer
NCT00525460Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
NCT03789110NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer
NCT02423148Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer
NCT06565052The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
NCT00585078Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
NCT00859040Monthly SOM230C for Recurrent or Progressive Meningioma
NCT01647607Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
NCT02279004A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT06758102Dance Study for Post-surgical Pain in Breast Cancer Survivors
NCT00165581High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma
NCT01838564The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT00542451Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
NCT03410875A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
NCT03289039Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer